← Back to Search

Early Intervention Group for Respiratory Distress Syndrome (LINK Trial)

N/A
Waitlist Available
Led By Gordon D. Rubenfeld, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at month 6
Awards & highlights

LINK Trial Summary

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a severe lung condition that causes respiratory failure. Individuals with ALI/ARDS often require the use of a respirator or artificial breathing machine, known as a mechanical ventilator, while in an intensive care unit (ICU). Research has shown that lung protective ventilation (LPV), a type of mechanical ventilation technique, is an effective way to reduce the number of deaths due to ALI/ARDS. This study will evaluate the effectiveness of a Web-based educational program that aims to educate ICU clinicians about the use of LPV in patients with ALI/ARDS.

Eligible Conditions
  • Respiratory Distress Syndrome

LINK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of eligible patients with ALI/ARDS who are receiving LPV

LINK Trial Design

2Treatment groups
Active Control
Group I: Early Intervention GroupActive Control1 Intervention
Group II: Delayed Intervention GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
657 Previous Clinical Trials
1,551,191 Total Patients Enrolled
4 Trials studying Respiratory Distress Syndrome
84 Patients Enrolled for Respiratory Distress Syndrome
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,406 Total Patients Enrolled
63 Trials studying Respiratory Distress Syndrome
41,132 Patients Enrolled for Respiratory Distress Syndrome
Gordon D. Rubenfeld, MDPrincipal InvestigatorUniversity of Toronto, Sunnybrook Health Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby May 2025